or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    FUSN A Fusion Pharmaceuticals Inc. -0.19
    CGEM A Cullinan Management, Inc. 2.79
    TCRX B TScan Therapeutics, Inc. -1.04
    STTK B Shattuck Labs, Inc. -2.88
    CRIS B Curis, Inc. -0.91
    ADCT B ADC Therapeutics SA 3.59
    CLLS B Cellectis S.A. 0.00
    ALXO B ALX Oncology Holdings Inc. -7.58
    SLS B SELLAS Life Sciences Group, Inc. -1.48
    MRUS C Merus N.V. 1.81
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Acute Myeloid Leukemia Medicine Clinical Medicine Antibodies Biopharmaceutical Cancer Immunotherapy Hematologic Malignancies Immunology Oncology Ovarian Cancer Advanced Solid Tumors Biotechnology Breast Cancer Carcinoma Drugs Immune System Life Sciences Lymphoma Monoclonal Antibodies

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    FRNW D Fidelity Clean Energy ETF 1.37
    PBD D PowerShares Global Clean Energy Portfolio 1.1
    GERM C ETFMG Treatments Testing and Advancements ETF 0.73
    RNRG D Global X Renewable Energy Producers ETF 0.66
    TAN D Invesco Solar ETF 0.62
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare FRNW to GERM Compare PBD to GERM Compare PBD to TAN

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 2 CLLS Cellectis announces CFO departure
        May 2 CLLS Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
        May 2 FUSN Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 2 TCRX AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 2 STTK Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates
        May 2 STTK Shattuck Labs GAAP EPS of -$0.37, revenue of $1.11M
        May 2 STTK Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
        May 1 SLS Sellas reports positive Phase 2 data from AML study, files for patent
        May 1 TCRX TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        May 1 SLS SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
        Apr 30 ALXO ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer
        Apr 30 CRIS Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
        Apr 29 CLLS Cellectis GAAP EPS of -$0.64 misses by $0.43, revenue of $1.99M misses by $14.13M
        Apr 29 CLLS Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
        Apr 29 CGEM Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
        Apr 29 CGEM Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
        Apr 29 MRUS Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
        Apr 29 SLS SELLAS Life Sciences announces IDMC's recommendation of continuing REGAL phase 3 study without modifications
        Apr 29 SLS SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study
        Apr 29 CGEM Cullinan Therapeutics appoints CFO
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Biotechnology Medicine Cancer Immunotherapy Immunology Tumor Antibodies Biopharmaceutical Clinical Medicine Immune System Treatment Of Cancer Antibody Cancer Treatment Cell Therapy Metastatic Disease Oncology Stem Cell Virotherapy Acute Kidney Injury Acute Leukemia
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags